Disc Medicine, Inc. logo IRON - Disc Medicine, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $103.33 DETAILS
HIGH: $125.00
LOW: $80.00
MEDIAN: $105.00
CONSENSUS: $103.33
UPSIDE: 54.64%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.1 0 0.1 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.1) 0 (0.1) 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 45.8 46.2 50.2 46.3 27.8 24.8 24.7 23.5 23.7 22.6 14.4 12.1 20.2 20.6 7.9 7.7 7.8 12.6 13.5 10.8 11.8 0 6.7 5.5 8.2
SG&A Expenses 23.6 20.7 17.4 15.1 12.2 9.8 8.2 7.4 7.8 7.1 4.5 5.2 4.9 0.7 2.6 4.3 2.1 5.1 5.0 5.5 4.7 (0.5) 1.2 1.1 1.4
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (6.6) 0 0 0
Operating Expenses 69.4 67.0 67.6 61.4 39.9 34.5 32.9 30.9 31.5 29.7 19.0 17.3 25.1 21.3 10.5 12.0 10.0 17.7 18.4 16.3 16.5 (7.1) 7.9 6.7 9.6
Operating Income
Operating Income (69.5) (67.0) (67.7) (61.4) (39.9) (34.5) (32.9) (30.9) (31.5) (29.7) (19.0) (17.3) (25.1) (21.3) (10.5) (12.0) (10.0) (17.7) (18.4) (16.3) (16.5) 7.1 (7.9) (6.7) (9.6)
Interest Expense 0 0.9 0.9 0.9 0.9 0.6 0 0 0 0 0 0 0 0.1 0.1 0.1 1.8 4.5 2.0 0.1 0.2
Interest Income 6.9 7.4 6.4 7.1 6.9 5.8 6.4 4.6 4.5 4.7 4.8 2.9 2.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Profitability
EBITDA (69.4) (59.5) (61.2) (54.2) (33.0) (13.3) (32.8) (26.2) (26.9) (29.7) (18.9) (17.3) (25.1) (21.9) (10.5) (12.0) (9.9) (17.7) (18.4) (16.3) (17.1) 7.2 (7.9) (6.6) (9.5)
EBIT (69.5) (59.6) (61.3) (54.3) (33.1) (13.3) (32.9) (26.3) (26.9) (29.7) (19.0) (17.3) (25.1) (22.0) (10.5) (12.0) (10.0) (17.7) (18.4) (16.3) (17.2) 7.1 (8.0) (6.7) (9.6)
Income Before Tax (63.5) (60.4) (62.2) (55.2) (34.0) (29.3) (26.5) (26.3) (26.9) (23.5) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
Income Tax Expense 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
Per Share Data
EPS (Basic) -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
EPS (Diluted) -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
Shares Outstanding 38.5 35.3 35.2 35.0 33.3 29.9 29.9 25.6 24.8 23.6 24.3 21.5 19.0 1.0 1.0 0.9 0.9 2.6 4.3 4.3 3.2 1.6 1.6 1.6 1.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 88.9 91.1 140.7 127.3 122.7 192.4 192.6 280.7 342.6 360.4 370.5 377.6 236.4 194.6 101.7 108.7 119.1 88.0 150.1 167.5 185.0 4.5
Short-Term Investments 641.2 700.0 475.3 522.6 572.0 297.4 294.7 220.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 17.3 12.7 11.2 11.6 10.9 3.7 5.8 7.3 9.3 0 3.7 4.1 5.7 0 0 0 0.3 (0.8) 0 0 0 0
Total Current Assets 747.5 803.9 627.2 661.6 705.6 493.6 493.2 508.2 351.9 365.7 374.3 381.7 242.1 198.5 104.7 113.1 124.1 90.5 154.8 171.3 188.6 5.1
Non-Current Assets
Property, Plant & Equipment 2.0 2.3 2.4 2.6 2.8 2.3 1.8 1.7 2.0 2.1 2.1 2.3 1.5 1.6 0 0 0 1.7 0.2 0.2 0.2 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.3 0 0
Other Non-Current Assets 0.7 0.7 0.8 0.8 0.8 0.8 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 1.4 0.2 0.2 0.2 0.2 0.6 0.5 3.0
Total Non-Current Assets 2.8 3.0 3.3 3.5 3.7 3.2 2.0 2.0 2.2 2.3 2.2 2.4 1.6 1.7 1.4 0.2 0.2 1.9 0.7 1.1 0.8 3.3
Total Assets 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Current Liabilities
Account Payables 11.8 9.0 7.3 6.3 6.7 7.9 3.6 4.7 5.3 12.6 8.5 5.2 5.6 16.2 1.1 1.6 5.1 2.6 0.9 1.5 3.6 2.4
Short-Term Debt 0.4 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 2.9 4.2 5 5 5 5 16.7
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 14.5 27.0 0 4.2 1.8 7.2 4.6 3.5 2.2 5.8 0 2.0 3.1 0 0 0 0 1.4 4.9 0 0 0
Total Current Liabilities 31.1 36.6 26.7 20.6 18.7 23.3 25.5 20.3 14.9 21.4 14.4 9.7 10.0 22.6 1.5 6.4 12.7 13.4 12.7 11.5 13.8 24.9
Non-Current Liabilities
Long-Term Debt 29.4 1.3 28.9 28.7 28.5 28.3 0 0 0 0 0 0 0 0 0 0 0 0.4 1.6 2.9 4.1 5.0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 29.2 0.0 0 0 0 0 0 0 0 1.5 1.5 0 0 0 0 0 141.5 0.4 0.3 0.3 0.4
Total Non-Current Liabilities 30.6 30.4 30.3 30.3 30.2 29.9 1.7 1.1 1.3 1.4 3.1 3.3 0.9 1.0 0 0 0 143.2 2.0 3.2 4.4 5.3
Total Liabilities 61.8 67.1 57.1 50.9 48.9 53.2 27.2 21.4 16.1 22.9 17.5 13.0 10.9 23.6 1.5 6.4 12.7 156.6 14.7 14.7 18.2 30.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0
Retained Earnings (573.7) (510.2) (449.7) (387.3) (332.1) (298.0) (268.5) (241.9) (215.6) (188.6) (165.1) (150.9) (135.0) (112.2) (210.3) (207.0) (199.9) (65.4) (166.9) (148.3) (131.9) (112.8)
Accumulated Other Comprehensive Income (0.6) 1.0 0.7 0.3 0.5 0.3 0.7 (0.1) 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0
Total Stockholders' Equity 688.4 739.8 573.4 614.2 660.4 443.6 468.0 488.8 338.1 345.1 359.0 371.2 232.9 176.6 104.6 106.9 111.6 (64.2) 140.9 157.7 171.2 (21.9)
Total Liabilities & Equity 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Debt Metrics
Total Debt 31.1 1.9 31.0 30.9 30.6 30 1.8 1.8 2.0 2.1 2.0 2.1 1.3 1.3 0 2.9 4.2 7.1 6.6 7.9 9.1 21.6
Net Debt (57.9) (89.3) (109.7) (96.4) (92.0) (162.4) (190.8) (278.8) (340.6) (358.3) (368.6) (375.5) (235.2) (193.3) (101.7) (105.7) (114.9) (81.0) (143.4) (159.6) (175.9) 17.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) (14.3) (10.0) (6.8) (9.7)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Stock-Based Compensation 0 0 9.5 8.4 6.4 4.3 4.3 4.1 4.1 1.9 1.3 1.3 1.0 0 0.4 0.4 0.3 0 1.7 2.9 1.6 0.6 0.2 0.1 0.1
Change in Working Capital (10.0) 8.4 6.3 0.3 (7.8) (2.8) 7.4 7.2 (10.9) 5.2 6.2 0.3 (13.8) 11.7 0.0 2.4 (4.2) 3.1 0.7 (2.4) (0.1) 0.4 0.9 (0.5) (0.4)
Other Non-Cash Items 11.2 8.7 (1.4) (1.5) (5.9) 0.4 (2.5) (0.4) 0.1 (1.4) (0.8) 1.6 0.1 (3.2) 6.0 (2.4) (0.0) 34.1 0.0 0.0 2.5 4.4 2.0 0.0 0.1
Operating Cash Flow (62.2) (43.3) (47.8) (47.9) (41.4) (27.6) (17.4) (15.4) (33.6) (17.8) (7.5) (12.7) (35.5) (12.4) (9.7) (9.2) (13.7) 19.5 (16.1) (15.9) (15.0) (8.9) (6.9) (7.0) (9.9)
Investing Activities
Capital Expenditure 0 (0.0) (0.0) (0.0) (0.9) (0.4) 0.0 0.0 (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) 0 0 0 (0.0) 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (93.8) (358.3) (85.4) (58.6) (347.2) (72.8) (94.1) (219.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 152.1 135.4 135 110.4 75.5 71.8 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 58.3 (222.9) 49.5 51.7 (272.6) (1.4) (71.1) (219.7) (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) 0 (0.0) 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 27.6 0 0 0 0 0 0 0 5.4 (2.9) (1.2) (1.2) 3.3 (1.2) (1.2) (0.8) 0 14 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.7 0.6 0 0 10.2 0.4 0.6 0.6 1.1 0.8 0.6 10.5 28.5 95.3 2.9 1.3 1.3 (195.9) 0 (0.3) 196.3 0.1 0 0.0 0.0
Financing Cash Flow 1.7 216.7 11.6 0.9 244.3 28.8 0.4 173.2 15.9 7.8 0.5 153.9 77.3 154.3 0.0 0.1 0.1 (102.7) (1.2) (1.6) 195.5 0.1 14.0 0.0 20.1
Cash Position
Net Change in Cash 7.7 (59.5) 13.3 4.7 (69.8) (0.2) (88.0) (62.0) (17.8) (10.0) (7.1) 141.1 41.8 93.1 (9.7) (9.1) (13.7) (61.9) (17.4) (17.5) 180.5 (8.7) 1.4 (7.0) 10.2
Cash at Beginning 81.2 140.7 127.6 122.9 192.7 192.9 280.9 342.9 360.6 370.7 377.7 236.6 194.8 101.7 65.3 74.5 88.2 150.1 167.8 185.3 4.8 13.5 0.0 13.5 3.3
Cash at End 88.9 81.2 140.9 127.6 122.9 192.7 192.9 280.9 342.9 360.6 370.7 377.7 236.6 194.8 55.6 65.3 74.5 88.2 150.4 167.8 185.3 4.8 1.4 6.5 13.5
Free Cash Flow (62.2) (43.3) (47.8) (48.0) (42.2) (28.0) (17.4) (15.4) (33.7) (17.8) (7.5) (12.7) (35.5) (12.6) (9.7) (9.2) (13.8) 19.5 (16.2) (15.9) (15.0) (8.9) (7.0) (7.0) (9.9)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.1) 0 (0.1) 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (69.5) (67.0) (67.7) (61.4) (39.9) (34.5) (32.9) (30.9) (31.5) (29.7) (19.0) (17.3) (25.1) (21.3) (10.5) (12.0) (10.0) (17.7) (18.4) (16.3) (16.5) 7.1 (7.9) (6.7) (9.6)
Net Income (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
EPS (Diluted) -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
Balance Sheet
Cash & Equivalents 88.9 91.1 140.7 127.3 122.7 192.4 192.6 280.7 342.6 360.4 370.5 377.6 236.4 194.6 101.7 108.7 119.1 88.0 150.1 167.5 185.0 4.5
Total Assets 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Total Debt 31.1 1.9 31.0 30.9 30.6 30 1.8 1.8 2.0 2.1 2.0 2.1 1.3 1.3 0 2.9 4.2 7.1 6.6 7.9 9.1 21.6
Stockholders' Equity 688.4 739.8 573.4 614.2 660.4 443.6 468.0 488.8 338.1 345.1 359.0 371.2 232.9 176.6 104.6 106.9 111.6 (64.2) 140.9 157.7 171.2 (21.9)
Cash Flow
Operating Cash Flow (62.2) (43.3) (47.8) (47.9) (41.4) (27.6) (17.4) (15.4) (33.6) (17.8) (7.5) (12.7) (35.5) (12.4) (9.7) (9.2) (13.7) 19.5 (16.1) (15.9) (15.0) (8.9) (6.9) (7.0) (9.9)
Capital Expenditure 0 (0.0) (0.0) (0.0) (0.9) (0.4) 0.0 0.0 (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) 0 0 0 (0.0) 0 0
Free Cash Flow (62.2) (43.3) (47.8) (48.0) (42.2) (28.0) (17.4) (15.4) (33.7) (17.8) (7.5) (12.7) (35.5) (12.6) (9.7) (9.2) (13.8) 19.5 (16.2) (15.9) (15.0) (8.9) (7.0) (7.0) (9.9)